Rob Woodman

Partner @ Panakes
Summary
Rob Woodman is a highly accomplished professional with a strong background in Oncology, Cancer Biology, Biochemistry, and Molecular Biology.
He holds a PhD in Oncology and Cancer Biology from the University of Cambridge and an MSc in Biochemistry and Molecular Biology from the University of Oxford.
Rob Woodman currently serves as a Partner at Panakes Partners, showcasing his expertise in the healthcare and biotechnology industry.
His vast experience also includes numerous roles as a Non-Executive Director at various organizations such as Catamaran Bio, Abintus Bio, Inc., Obsidian Therapeutics, and TranSINE Therapeutics.
Additionally, Rob Woodman has held positions as a Senior Partner and Head of Genesis Labs at Takeda Ventures, Inc., as well as a Healthcare Investor at Touchstone Innovations.
His strategic leadership is evident from his former roles as a Non-Executive Director at several prominent biotechnology companies like Emendo Biotherapeutics, BiomX Inc, and Enterprise Therapeutics.
Rob Woodman's extensive professional history includes engagements with STORM Therapeutics Limited, Inivata Limited, Crescendo Biologics Limited, and Mission Therapeutics.
Furthermore, he has served as a Director Healthcare Ventures at Imperial Innovations and as a Principal at Sofinnova Partners, demonstrating his versatile skill set and commitment to driving innovation in the healthcare sector.